SoRelle Elliott D, Luftig Micah A
Department of Molecular Genetics & Microbiology, Center for Virology, Duke University, Durham, North Carolina, USA.
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0011923. doi: 10.1128/mmbr.00119-23. Epub 2025 Jan 16.
SUMMARYInfection has long been hypothesized as the cause of multiple sclerosis (MS), and recent evidence for Epstein-Barr virus (EBV) as the trigger of MS is clear and compelling. This clarity contrasts with yet uncertain viral mechanisms and their relation to MS neuroinflammation and demyelination. As long as this disparity persists, it will invigorate virologists, molecular biologists, immunologists, and clinicians to ascertain how EBV potentiates MS onset, and possibly the disease's chronic activity and progression. Such efforts should take advantage of the diverse body of basic and clinical research conducted over nearly two centuries since the first clinical descriptions of MS plaques. Defining the contribution of EBV to the complex and multifactorial pathology of MS will also require suitable experimental models and techniques. Such efforts will broaden our understanding of virus-driven neuroinflammation and specifically inform the development of EBV-targeted therapies for MS management and, ultimately, prevention.
摘要
长期以来,感染一直被认为是多发性硬化症(MS)的病因,最近有明确且令人信服的证据表明,爱泼斯坦-巴尔病毒(EBV)是MS的触发因素。这种明确性与尚不确定的病毒机制及其与MS神经炎症和脱髓鞘的关系形成对比。只要这种差异持续存在,就会激励病毒学家、分子生物学家、免疫学家和临床医生去确定EBV如何促进MS的发病,以及可能影响该疾病的慢性活动和进展。自首次对MS斑块进行临床描述以来,在近两个世纪里开展了大量基础和临床研究,此类研究应充分利用这些研究成果。确定EBV对MS复杂多因素病理的作用还需要合适的实验模型和技术。这些努力将拓宽我们对病毒驱动的神经炎症的理解,并具体指导针对EBV的疗法的开发,用于MS的管理以及最终的预防。